Jiefang Chen
Overview
Explore the profile of Jiefang Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu F, Xu Z, Chen G, Xu X, Cao H, Chen J
Front Med (Lausanne)
. 2025 Jan;
11():1445550.
PMID: 39850100
Introduction: Podocytopathies are a uniquely renal disease syndrome, in which direct or indirect podocyte injury leads to proteinuria or nephrotic syndrome. Of the many factors that contribute to podocytopathies, the...
2.
Jin M, Ye K, Hu D, Chen J, Wu S, Chi S
Brain Res
. 2024 Jul;
1842:149097.
PMID: 38950810
Background: Parkinson's disease (PD) is the fastest growing neurological disease. Currently, there is no disease-modifying therapy to slow the progression of the disease. Danggui buxue decoction (DBD) is widely used...
3.
Wang Z, Huang Y, Wang S, Chen J, Meiduo G, Jin M, et al.
Prion
. 2024 Jan;
18(1):1-10.
PMID: 38226945
Fatal familial insomnia (FFI) is a rare autosomal dominant genetic neurodegenerative disease. Generally, FFI patients will develop rapidly progressive dementia, sleep disturbance, autonomic dysfunction, and so on. Cerebrospinal fluid examination...
4.
Chen J, Gao F, Xu Z, Liu Y, Hu M, Yuan C, et al.
Chem Commun (Camb)
. 2024 Jan;
60(11):1440-1443.
PMID: 38206371
A terbium(III) complex-based time-resolved luminescence probe for selenocysteine can inhibit selenoprotein activity a selenolate-triggered cleavage reaction of sulfonamide bonds in living cells.
5.
Gao F, Chen J, Zhou Y, Cheng L, Hu M, Wang X
RSC Med Chem
. 2023 Nov;
14(11):2231-2245.
PMID: 37974955
Alzheimer's disease (AD) is the most common form of neurodegenerative dementia. As a multifactorial disease, AD involves several etiopathogenic mechanisms, in which multiple pathological factors are interconnected with each other....
6.
Chen J, Chen G, Xu X, Chen L, Zhang J, Liu F
Front Pharmacol
. 2023 Sep;
14:1232114.
PMID: 37731738
To summarize and clarify the current research status and indicate possible future directions in the field of autophagy in ischemic stroke, we performed a comprehensive and multidimensional bibliometric analysis of...
7.
Wang Y, Chen J, Gao F, Hu M, Wang X
Org Biomol Chem
. 2023 May;
21(22):4540-4552.
PMID: 37212028
Aggregation of amyloid-β (Aβ) peptides is characteristic of Alzheimer's disease (AD), which is the most common neurodegenerative disorder. Increasing evidence shows that Aβ oligomers, the intermediates during aggregation, rather than...
8.
Chen J, Su Y, Pi S, Hu B, Mao L
Front Cardiovasc Med
. 2023 May;
10:1179643.
PMID: 37153455
[This corrects the article DOI: 10.3389/fcvm.2021.682389.].
9.
Chi S, Wen X, Yu Y, Wang G, Zhang J, Xue C, et al.
Parkinsonism Relat Disord
. 2022 Nov;
106:105218.
PMID: 36442365
Background: Emerging evidence suggests that repetitive transcranial magnetic stimulation (rTMS) generally improves Parkinson's disease (PD) motor symptoms. However, personal responses to rTMS might be different. In this study, we explore...
10.
Li Z, Bi R, Sun S, Chen S, Chen J, Hu B, et al.
Oxid Med Cell Longev
. 2022 Nov;
2022:8418820.
PMID: 36439687
Acute ischemic stroke is a serious life-threatening disease that affects almost 600 million people each year throughout the world with a mortality of more than 10%, while two-thirds of survivors...